Advertisement
Screener

Lineage Cell Therapeutics, Inc. (LCTX) Shares Outstanding (Cover Page)

2.0 / 5 stars · 28/69 Roast Me

Lineage Cell Therapeutics, Inc. Shares Outstanding (Cover Page)

Lineage Cell Therapeutics, Inc. (LCTX) had Shares Outstanding (Cover Page) of 252.91 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Cover Page

dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06

  • 2026-08-03: Entity Common Stock, Shares Outstanding 252.91M shares.
  • 2026-05-08: Entity Common Stock, Shares Outstanding 249.30M shares.
  • 2026-03-05: Entity Common Stock, Shares Outstanding 249.09M shares.
  • 2025-10-31: Entity Common Stock, Shares Outstanding 230.33M shares.
Period endEntity Common Stock, Shares Outstanding
2026-08-03252.91M shares
10-Q · filed 2026-08-06
2026-05-08249.30M shares
10-Q · filed 2026-05-12
2026-03-05249.09M shares
10-K · filed 2026-03-05
2025-10-31230.33M shares
10-Q · filed 2025-11-06
2025-08-06228.36M shares
10-Q · filed 2025-08-12
2025-05-07228.36M shares
10-Q · filed 2025-05-13
2025-03-04228.36M shares
10-K · filed 2025-03-10
2024-11-08188.84M shares
10-Q · filed 2024-11-14
2024-08-02188.84M shares
10-Q · filed 2024-08-08
2024-05-03188.80M shares
10-Q · filed 2024-05-09
2024-03-01188.53M shares
10-K · filed 2024-03-07
2023-11-03174.99M shares
10-Q · filed 2023-11-09
2023-08-04174.99M shares
10-Q · filed 2023-08-10
2023-05-05170.17M shares
10-Q · filed 2023-05-11
2023-04-26170.17M shares
10-K/A · filed 2023-04-27
2023-03-03170.15M shares
10-K · filed 2023-03-09
2022-11-04169.98M shares
10-Q · filed 2022-11-10
2022-08-05169.76M shares
10-Q · filed 2022-08-11
2022-05-06169.73M shares
10-Q · filed 2022-05-12
2022-03-04169.71M shares
10-K · filed 2022-03-10
2021-11-05168.56M shares
10-Q · filed 2021-11-10
2021-08-06167.46M shares
10-Q · filed 2021-08-12
2021-05-07162.14M shares
10-Q · filed 2021-05-13
2021-03-05161.64M shares
10-K · filed 2021-03-11
2020-11-03149.99M shares
10-Q · filed 2020-11-04
2020-08-05149.98M shares
10-Q · filed 2020-08-06
2020-05-05149.82M shares
10-Q · filed 2020-05-07
2020-03-05149.81M shares
10-K · filed 2020-03-12
2019-11-08149.79M shares
10-Q · filed 2019-11-12
2019-08-06149.64M shares
10-Q · filed 2019-08-08
2019-05-06149.64M shares
10-Q · filed 2019-05-09
2019-03-11149.36M shares
10-K · filed 2019-03-14
2018-11-07126.96M shares
10-Q · filed 2018-11-08
2018-07-23126.88M shares
10-Q · filed 2018-08-02
2018-05-04126.87M shares
10-Q · filed 2018-05-10
2018-03-13126.87M shares
10-K · filed 2018-03-15
2017-11-01126.87M shares
10-Q · filed 2017-11-09
2017-08-09115.80M shares
10-Q · filed 2017-08-09
2017-05-05110.88M shares
10-Q · filed 2017-05-10
2017-03-09110.85M shares
10-K · filed 2017-03-16
2016-10-13103.39M shares
10-Q · filed 2016-11-04
2016-08-05103.39M shares
10-Q · filed 2016-08-09
2016-05-0294.96M shares
10-Q · filed 2016-05-10
2016-03-0494.89M shares
10-K · filed 2016-03-15
2015-11-0694.89M shares
10-Q · filed 2015-11-09
2015-08-0383.28M shares
10-Q · filed 2015-08-10
2015-05-0183.27M shares
10-Q · filed 2015-05-08
2015-03-0983.15M shares
10-K · filed 2015-03-11
2014-11-0583.12M shares
10-Q · filed 2014-11-07
2014-08-0673.69M shares
10-Q · filed 2014-08-11
2014-05-0972.15M shares
10-Q · filed 2014-05-12
2014-03-0569.60M shares
10-K · filed 2014-03-17
2013-11-0867.20M shares
10-Q · filed 2013-11-12
2013-08-0757.94M shares
10-Q · filed 2013-08-09
2013-05-0955.73M shares
10-Q · filed 2013-05-10
2013-03-1454.91M shares
10-K · filed 2013-03-18
2012-10-2350.87M shares
10-Q · filed 2012-11-09
2012-08-0750.87M shares
10-Q · filed 2012-08-09
2012-05-0950.34M shares
10-Q · filed 2012-05-10
2012-03-0550.32M shares
10-K · filed 2012-03-14
2011-10-3150.25M shares
10-Q · filed 2011-11-08
2011-07-1948.87M shares
10-Q · filed 2011-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Invivyd, Inc. (IVVD)United States$0.270B-2.42
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51